On Friday morning, the stock market appeared poised for a rebound, particularly following three sessions of significant losses for the S&P 500 and Nasdaq indexes. Both indexes had recently undergone a notable rotation away from technology stocks, raising concerns among investors. Despite steep post-earnings declines for tech giant Amazon, Nasdaq futures showed signs of recovery, indicating optimism among traders, even as it approached its worst weekly performance since April 2025.
Meanwhile, Bitcoin exhibited signs of resilience, bouncing back from lows that nearly pushed it below the $60,000 mark. This volatility in tech equities and precious metals, especially silver, triggered a series of exchange-traded fund sales and liquidations. Bitcoin reached a remarkable high of over $126,000 last October, leaving many to wonder how the cryptocurrency will navigate the current market turbulence.
In the realm of Amazon, analysts have raised questions about the company’s spending habits. The retail giant’s ambitious $200 billion capital expenditures plan for 2026 was scrutinized, particularly in light of its recent profit forecast, which fell short of expectations, leading to an 8% decline in the stock. However, the final quarter of 2025 showed promise, as Amazon’s cloud business posted robust growth that exceeded market estimates.
Barclays reaffirmed its “buy” rating on KKR, despite the private equity firm’s heavy investments in enterprise software companies, which have faced harsh market reactions amid fears that AI advancements might render them obsolete. While Club name Salesforce was experiencing a slight recovery, it still struggled with a 10.5% loss throughout the week.
In another notable move, JPMorgan downgraded its rating on industrial gas leader Linde from “buy” to “hold,” citing concerns about pricing pressures, possibly linked to declining helium prices. Even though Linde reported better-than-expected quarterly earnings and revenue, its cautious guidance prompted a mild sell-off in the stock.
On the healthcare front, the FDA made headlines by blocking Hims & Hers’ GLP-1 copycat drugs due to safety concerns, causing the company’s shares to plummet nearly 9%. This announcement coincided with Novo Nordisk’s stock rebounding by 7%, following the previous day’s drop due to heightened competition in the weight loss pharmaceutical space. Eli Lilly, another competitor, also faced stock fluctuations but appeared to recover some ground in early trading.
Automotive giant Stellantis faced a turbulent morning after announcing a substantial $26 billion restructuring charge. This sweeping overhaul will scale back on electric vehicle initiatives and reintroduce V8 engines to its U.S. lineup. CEO Antonio Filosa asserted that the company is better positioned as a unified entity, although shares fell 24% in response to the news.
On a positive note, Goldman Sachs upgraded Vistra, an electricity and power generation firm, to “hold” from “buy,” following its recent stock pullback. The upgrade was supported by recent contractual agreements with Meta Platforms, showcasing the company’s ability to secure significant power purchase agreements.
Additionally, Wells Fargo raised its price target for Bloom Energy from $95 to $130, citing strong fourth-quarter earnings that beat analyst expectations. This positive sentiment resulted in a significant 13% rise in the company’s shares.
Lastly, shares of Reddit rose 7% after the company reported strong quarterly results, although Piper Sandler adjusted its price target downward from $290 to $205. Despite the modest beat, the firm noted optimistic guidance for 2026 and highlighted a $1 billion share buyback program.
Investors are encouraged to stay informed as these developments unfold, reflecting shifting dynamics across various sectors amidst ongoing market challenges.
